Kitawaki J, Noguchi T, Amatsu T, Maeda K, Tsukamoto K, Yamamoto T, Fushiki S, Osawa Y, Honjo H
Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine, Japan.
Biol Reprod. 1997 Sep;57(3):514-9. doi: 10.1095/biolreprod57.3.514.
To determine whether local estrogen production takes place in endometriotic or adenomyotic tissues, in eutopic endometrium from patients with endometriosis or adenomyosis, and in normal endometrium, tissue specimens were examined by immunohistochemistry, catalytic activity, and mRNA expression for aromatase cytochrome P450 (P450arom). P450arom was immunohistochemically localized in the cytoplasm of glandular cells of endometriotic and adenomyotic tissues, and of eutopic endometrium from patients with the respective diseases, whereas estrogen receptors and progesterone receptors were localized in the nuclei of the glandular cells and stroma. Aromatase activity in the microsomal fraction of adenomyotic tissues was inhibited by the addition of danazol, aromatase inhibitors, and anti-human placental P450arom monoclonal antibody (mAb3-2C2) in a manner similar to such inhibition in other human tissues. Reverse transcription polymerase chain reaction and Southern blot analysis also revealed P450arom mRNA in these tissues. However, neither P450arom protein activity nor mRNA was detected in endometrial specimens obtained from normal menstruating women with cervical carcinoma in situ but without any other gynecological disease. These results suggest that at a local level, endometriotic and adenomyotic tissues produce estrogens, which may be involved in the tissue growth through interacting with the estrogen receptor.
为了确定局部雌激素生成是否发生在子宫内膜异位症或子宫腺肌病组织、子宫内膜异位症或子宫腺肌病患者的在位内膜以及正常子宫内膜中,通过免疫组织化学、催化活性和芳香化酶细胞色素P450(P450arom)的mRNA表达对组织标本进行了检测。P450arom免疫组织化学定位在子宫内膜异位症和子宫腺肌病组织以及相应疾病患者的在位内膜的腺细胞胞质中,而雌激素受体和孕激素受体则定位在腺细胞和基质的细胞核中。子宫腺肌病组织微粒体部分中的芳香化酶活性可被添加达那唑、芳香化酶抑制剂和抗人胎盘P450arom单克隆抗体(mAb3-2C2)所抑制,其抑制方式与在其他人体组织中的抑制方式相似。逆转录聚合酶链反应和Southern印迹分析也揭示了这些组织中存在P450arom mRNA。然而,在患有原位宫颈癌但无任何其他妇科疾病的正常月经妇女的子宫内膜标本中,未检测到P450arom蛋白活性或mRNA。这些结果表明,在局部水平上,子宫内膜异位症和子宫腺肌病组织可产生雌激素,这些雌激素可能通过与雌激素受体相互作用参与组织生长。